Richcore Bio (02149.HK) issued 0.143 billion shares of domestic shares, with a subscription price of 5.59 RMB per share.

AASTOCKS · Nov 12 08:54

Ruikang Biology-B (02149.HK) announced that the board of directors approved the proposal to issue domestic shares at a targeted amount of not more than 0.143 billion shares at yesterday's (11th) meeting in accordance with special authorization to the subscribers.

In addition, Ruikang Biology signed a share subscription agreement with Yangtze River Pharmaceutical Group yesterday. It is reported that Yangtze River Pharmaceutical Group conditionally agreed to subscribe for a total of 0.143 billion domestic shares issued by Ruikang Biology at a subscription price of 5.59 RMB per share. (js/w)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

瑞科生物(02149.HK)發行1.43億股內資股 認購價每股5.59人幣

Richcore Bio (02149.HK) issued 0.143 billion shares of domestic shares, with a subscription price of 5.59 RMB per share.

Risk Disclaimer

Statement

瑞科生物(02149.HK)發行1.43億股內資股認購價每股5.59人幣